Global Acromegaly Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4871626
- 60 Pages
- February 2022
- Pharmaceuticals
The United States Acromegaly Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Acromegaly Therapeutics market, reaching US$ million by the year 2028. As for the Europe Acromegaly Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Acromegaly Therapeutics players cover Novartis, IPSEN, Pfizer, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Acromegaly Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Octreotide
Pasireotide
Lanreotide
Pegvisomant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
IPSEN
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acromegaly Therapeutics Market Size 2017-2028
2.1.2 Acromegaly Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Acromegaly Therapeutics Segment by Type
2.2.1 Octreotide
2.2.2 Pasireotide
2.2.3 Lanreotide
2.2.4 Pegvisomant
2.3 Acromegaly Therapeutics Market Size by Type
2.3.1 Acromegaly Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Acromegaly Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Acromegaly Therapeutics Market Size by Application
2.5.1 Acromegaly Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
3 Acromegaly Therapeutics Market Size by Player
3.1 Acromegaly Therapeutics Market Size Market Share by Players
3.1.1 Global Acromegaly Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Acromegaly Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Acromegaly Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Acromegaly Therapeutics by Regions
4.1 Acromegaly Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Acromegaly Therapeutics Market Size Growth (2017-2022)
4.3 APAC Acromegaly Therapeutics Market Size Growth (2017-2022)
4.4 Europe Acromegaly Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Acromegaly Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Acromegaly Therapeutics Market Size by Country (2017-2022)
5.2 Americas Acromegaly Therapeutics Market Size by Type (2017-2022)
5.3 Americas Acromegaly Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acromegaly Therapeutics Market Size by Region (2017-2022)
6.2 APAC Acromegaly Therapeutics Market Size by Type (2017-2022)
6.3 APAC Acromegaly Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Acromegaly Therapeutics by Country (2017-2022)
7.2 Europe Acromegaly Therapeutics Market Size by Type (2017-2022)
7.3 Europe Acromegaly Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acromegaly Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Acromegaly Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Acromegaly Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Acromegaly Therapeutics Market Forecast
10.1 Global Acromegaly Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Acromegaly Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Acromegaly Therapeutics Forecast
10.1.3 APAC Acromegaly Therapeutics Forecast
10.1.4 Europe Acromegaly Therapeutics Forecast
10.1.5 Middle East & Africa Acromegaly Therapeutics Forecast
10.2 Americas Acromegaly Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Acromegaly Therapeutics Market Forecast
10.2.2 Canada Acromegaly Therapeutics Market Forecast
10.2.3 Mexico Acromegaly Therapeutics Market Forecast
10.2.4 Brazil Acromegaly Therapeutics Market Forecast
10.3 APAC Acromegaly Therapeutics Forecast by Region (2023-2028)
10.3.1 China Acromegaly Therapeutics Market Forecast
10.3.2 Japan Acromegaly Therapeutics Market Forecast
10.3.3 Korea Acromegaly Therapeutics Market Forecast
10.3.4 Southeast Asia Acromegaly Therapeutics Market Forecast
10.3.5 India Acromegaly Therapeutics Market Forecast
10.3.6 Australia Acromegaly Therapeutics Market Forecast
10.4 Europe Acromegaly Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Acromegaly Therapeutics Market Forecast
10.4.2 France Acromegaly Therapeutics Market Forecast
10.4.3 UK Acromegaly Therapeutics Market Forecast
10.4.4 Italy Acromegaly Therapeutics Market Forecast
10.4.5 Russia Acromegaly Therapeutics Market Forecast
10.5 Middle East & Africa Acromegaly Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Acromegaly Therapeutics Market Forecast
10.5.2 South Africa Acromegaly Therapeutics Market Forecast
10.5.3 Israel Acromegaly Therapeutics Market Forecast
10.5.4 Turkey Acromegaly Therapeutics Market Forecast
10.5.5 GCC Countries Acromegaly Therapeutics Market Forecast
10.6 Global Acromegaly Therapeutics Forecast by Type (2023-2028)
10.7 Global Acromegaly Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Acromegaly Therapeutics Product Offered
11.1.3 Novartis Acromegaly Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 IPSEN
11.2.1 IPSEN Company Information
11.2.2 IPSEN Acromegaly Therapeutics Product Offered
11.2.3 IPSEN Acromegaly Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 IPSEN Main Business Overview
11.2.5 IPSEN Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Acromegaly Therapeutics Product Offered
11.3.3 Pfizer Acromegaly Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
12 Research Findings and Conclusion
Table 1. Acromegaly Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Octreotide
Table 3. Major Players of Pasireotide
Table 4. Major Players of Lanreotide
Table 5. Major Players of Pegvisomant
Table 6. Acromegaly Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Acromegaly Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
Table 9. Acromegaly Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Acromegaly Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
Table 12. Global Acromegaly Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Acromegaly Therapeutics Revenue Market Share by Player (2020-2022)
Table 14. Acromegaly Therapeutics Key Players Head office and Products Offered
Table 15. Acromegaly Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Acromegaly Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Acromegaly Therapeutics Market Size Market Share by Regions (2017-2022)
Table 20. Americas Acromegaly Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Acromegaly Therapeutics Market Size Market Share by Country (2017-2022)
Table 22. Americas Acromegaly Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
Table 24. Americas Acromegaly Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
Table 26. APAC Acromegaly Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Acromegaly Therapeutics Market Size Market Share by Region (2017-2022)
Table 28. APAC Acromegaly Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
Table 30. APAC Acromegaly Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
Table 32. Europe Acromegaly Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Acromegaly Therapeutics Market Size Market Share by Country (2017-2022)
Table 34. Europe Acromegaly Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
Table 36. Europe Acromegaly Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Acromegaly Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Acromegaly Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Acromegaly Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Acromegaly Therapeutics
Table 45. Key Market Challenges & Risks of Acromegaly Therapeutics
Table 46. Key Industry Trends of Acromegaly Therapeutics
Table 47. Global Acromegaly Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Acromegaly Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Acromegaly Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Acromegaly Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Acromegaly Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Acromegaly Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 53. Novartis Details, Company Type, Acromegaly Therapeutics Area Served and Its Competitors
Table 54. Novartis Acromegaly Therapeutics Product Offered
Table 55. Novartis Acromegaly Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Novartis Main Business
Table 57. Novartis Latest Developments
Table 58. IPSEN Details, Company Type, Acromegaly Therapeutics Area Served and Its Competitors
Table 59. IPSEN Acromegaly Therapeutics Product Offered
Table 60. IPSEN Main Business
Table 61. IPSEN Acromegaly Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. IPSEN Latest Developments
Table 63. Pfizer Details, Company Type, Acromegaly Therapeutics Area Served and Its Competitors
Table 64. Pfizer Acromegaly Therapeutics Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Acromegaly Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Pfizer Latest Developments
List of Figures
Figure 1. Acromegaly Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acromegaly Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Acromegaly Therapeutics Market Size Market Share by Type in 2021
Figure 7. Acromegaly Therapeutics in Hospital
Figure 8. Global Acromegaly Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Acromegaly Therapeutics in Pharmacy
Figure 10. Global Acromegaly Therapeutics Market: Pharmacy (2017-2022) & ($ Millions)
Figure 11. Global Acromegaly Therapeutics Market Size Market Share by Application in 2021
Figure 12. Global Acromegaly Therapeutics Revenue Market Share by Player in 2021
Figure 13. Global Acromegaly Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Acromegaly Therapeutics Market Size 2017-2022 ($ Millions)
Figure 15. APAC Acromegaly Therapeutics Market Size 2017-2022 ($ Millions)
Figure 16. Europe Acromegaly Therapeutics Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Acromegaly Therapeutics Market Size 2017-2022 ($ Millions)
Figure 18. Americas Acromegaly Therapeutics Value Market Share by Country in 2021
Figure 19. Americas Acromegaly Therapeutics Consumption Market Share by Type in 2021
Figure 20. Americas Acromegaly Therapeutics Market Size Market Share by Application in 2021
Figure 21. United States Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Acromegaly Therapeutics Market Size Market Share by Region in 2021
Figure 26. APAC Acromegaly Therapeutics Market Size Market Share by Application in 2021
Figure 27. China Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Acromegaly Therapeutics Market Size Market Share by Country in 2021
Figure 34. Europe Acromegaly Therapeutics Market Size Market Share by Type in 2021
Figure 35. Europe Acromegaly Therapeutics Market Size Market Share by Application in 2021
Figure 36. Germany Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Acromegaly Therapeutics Market Size Market Share by Application in 2021
Figure 44. Egypt Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Acromegaly Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 50. APAC Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 51. Europe Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 53. United States Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. Canada Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. China Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Japan Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Korea Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. India Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Australia Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Germany Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. France Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. UK Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Italy Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Russia Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. Spain Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Israel Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Acromegaly Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
